CBAY - CymaBay Therapeutics GAAP EPS of -$0.28 beats by $0.02 November, 14 2022 04:17 PM CymaBay Therapeutics Inc. CymaBay Therapeutics press release ( NASDAQ: CBAY ): Q3 GAAP EPS of -$0.28 beats by $0.02 . Held $153.4 million in cash, cash equivalents and investments as of September 30, 2022. For further details see: CymaBay Therapeutics GAAP EPS of -$0.28 beats by $0.02